Back
Ultragenyx Pharmaceutical Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
RARE
Ultragenyx Pharmaceutical
Last Price:
$35.41
Seasonality Move:
12.55%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.69 | Buy |
| 20-day SMA: | 35.32 | Buy |
| 50-day SMA: | 39.17 | Sell |
| 200-day SMA: | 46.57 | Sell |
| 8-day EMA: | 34.91 | Buy |
| 20-day EMA: | 35.59 | Sell |
| 50-day EMA: | 38.24 | Sell |
| 200-day EMA: | 43.7 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.2 | Sell |
| Relative Strength Index (14 RSI): | 46.57 | Sell |
| Chaikin Money Flow: | -418057 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.55 - 38.67) | Sell |
| Bollinger Bands (100): | (37.61 - 46.03) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 35.40 while RARE 8-day simple moving average is 34.69, which is a Buy signal.
-
The stock price of RARE is 35.40 while Ultragenyx Pharmaceutical 20-day SMA is 35.32, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 39.17 while RARE share price is 35.40, making it a Sell technically.
-
RARE stock price is 35.40 and Ultragenyx Pharmaceutical 200-day simple moving average is 46.57, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
21
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $35.40. The Score for RARE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.3B
Price in USD:
35.40
Share Volume:
1M
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
29.59
Sell
21
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 35.40 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 35.40 while RARE 8-day exponential moving average is 34.91, which is a Buy signal.
-
The stock price of RARE is 35.40 while Ultragenyx Pharmaceutical 20-day EMA is 35.59, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 38.24 while RARE share price is 35.40, making it a Sell technically.
-
RARE stock price is 35.40 and Ultragenyx Pharmaceutical 200-day simple moving average is 43.70, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.74 per share, and an increase next year of $1.82 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is -1.2, suggesting Ultragenyx Pharmaceutical is a Sell
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 46.57, which suggest Ultragenyx Pharmaceutical is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (33.55 - 38.67), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (37.61 - 46.03), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.